Literature DB >> 33550566

The Future of Obsessive-Compulsive Spectrum Disorders: A Research Perspective.

T Vats1, N A Fineberg2,3,4, E Hollander5.   

Abstract

Obsessive-compulsive disorder (OCD) sits at the epicenter of a spectrum of related conditions (often referred to as obsessive-compulsive related disorders (OCRD) or obsessive-compulsive spectrum disorders (OCSD)) that can be as disabling as they are varied in presentation. Research in the field now encompasses diverse disciplines ranging from inflammatory mechanisms to computational psychiatry, to neurocognitive endophenotypes to functional imaging to pharmacogenomics to brain stimulation approaches. As these disorders become more clearly elucidated, there is a need to continually re-evaluate the implications of research findings and to incorporate these findings into new treatment approaches that benefit both patients and clinicians. Even the Diagnostic and Statistical Manual of Mental Disorders 5th Edition (DSM-5) is intended to be flexible and to incorporate validated and reliable biomarkers and neuroscience findings as they become available. This concluding chapter highlights just a few areas of study that promise to influence our understanding of the pathophysiology and clinical practice of OCRD. These include patient-centered outcomes research, the study of developmental brain trajectories in spectrum conditions, robot models of OCRDs, goal-directed versus habit-based behaviors, pharmacogenomics, problematic use of the Internet, and digital interventions. For example, digital medicine may become increasingly useful by identifying patients early on in the course of their illness; providing biomarkers to subtype patients; predicting treatment response; serving as a more proximal outcome measure of treatment response; or providing easily accessible and less costly forms of care. In order to address unmet clinical needs in OCRD, it is helpful to take an interdisciplinary perspective, and the work described in this collection of articles is likely to be invaluable in shaping the future of the field.
© 2021. Springer Nature Switzerland AG.

Entities:  

Keywords:  Digital interventions; Obsessive-compulsive disorder (OCD); Patient-centered outcomes research; Pharmacogenomics; Problematic use of the Internet (PUI); Robot model

Year:  2021        PMID: 33550566     DOI: 10.1007/7854_2020_208

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  11 in total

1.  A cybernetic model of obsessive-compulsive psychopathology.

Authors:  R K Pitman
Journal:  Compr Psychiatry       Date:  1987 Jul-Aug       Impact factor: 3.735

2.  Early intervention for obsessive compulsive disorder: An expert consensus statement.

Authors:  Naomi A Fineberg; Bernardo Dell'Osso; Umberto Albert; Giuseppe Maina; Daniel Geller; Lior Carmi; Nick Sireau; Susanne Walitza; Giacomo Grassi; Stefano Pallanti; Eric Hollander; Vlasios Brakoulias; Jose M Menchon; Donatella Marazziti; Konstantinos Ioannidis; Annemieke Apergis-Schoute; Dan J Stein; Danielle C Cath; Dick J Veltman; Michael Van Ameringen; Leonardo F Fontenelle; Roseli G Shavitt; Daniel Costa; Juliana B Diniz; Joseph Zohar
Journal:  Eur Neuropsychopharmacol       Date:  2019-02-14       Impact factor: 4.600

Review 3.  Human compulsivity: A perspective from evolutionary medicine.

Authors:  Dan J Stein; Haggai Hermesh; David Eilam; Cosi Segalas; Joseph Zohar; Jose Menchon; Randolph M Nesse
Journal:  Eur Neuropsychopharmacol       Date:  2015-12-10       Impact factor: 4.600

Review 4.  Current animal models of obsessive compulsive disorder: a critical review.

Authors:  Daphna Joel
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2006-02-07       Impact factor: 5.067

Review 5.  Pharmacogenetics of obsessive-compulsive disorders.

Authors:  Eva J Brandl; Daniel J Müller; Margaret A Richter
Journal:  Pharmacogenomics       Date:  2012-01       Impact factor: 2.533

Review 6.  Mapping Compulsivity in the DSM-5 Obsessive Compulsive and Related Disorders: Cognitive Domains, Neural Circuitry, and Treatment.

Authors:  Naomi A Fineberg; Annemieke M Apergis-Schoute; Matilde M Vaghi; Paula Banca; Claire M Gillan; Valerie Voon; Samuel R Chamberlain; Eduardo Cinosi; Jemma Reid; Sonia Shahper; Edward T Bullmore; Barbara J Sahakian; Trevor W Robbins
Journal:  Int J Neuropsychopharmacol       Date:  2018-01-01       Impact factor: 5.176

Review 7.  Glutamate-Modulating Drugs as a Potential Therapeutic Strategy in Obsessive-Compulsive Disorder.

Authors:  Zoya Marinova; De-Maw Chuang; Naomi Fineberg
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

Review 8.  A trans-diagnostic perspective on obsessive-compulsive disorder.

Authors:  C M Gillan; N A Fineberg; T W Robbins
Journal:  Psychol Med       Date:  2017-03-27       Impact factor: 7.723

9.  Enhanced avoidance habits in obsessive-compulsive disorder.

Authors:  Claire M Gillan; Sharon Morein-Zamir; Gonzalo P Urcelay; Akeem Sule; Valerie Voon; Annemieke M Apergis-Schoute; Naomi A Fineberg; Barbara J Sahakian; Trevor W Robbins
Journal:  Biol Psychiatry       Date:  2013-03-16       Impact factor: 13.382

Review 10.  Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders.

Authors:  Naomi A Fineberg; Eric Hollander; Stefano Pallanti; Susanne Walitza; Edna Grünblatt; Bernardo Maria Dell'Osso; Umberto Albert; Daniel A Geller; Vlasios Brakoulias; Y C Janardhan Reddy; Shyam Sundar Arumugham; Roseli G Shavitt; Lynne Drummond; Benedetta Grancini; Vera De Carlo; Eduardo Cinosi; Samuel R Chamberlain; Konstantinos Ioannidis; Carolyn I Rodriguez; Kabir Garg; David Castle; Michael Van Ameringen; Dan J Stein; Lior Carmi; Joseph Zohar; Jose M Menchon
Journal:  Int Clin Psychopharmacol       Date:  2020-07       Impact factor: 1.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.